Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Cruz-Flores, Salvador
START, NCT03021928: Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation	Active, not recruiting	3	200	US	Time-To-Treatment Randomization	University of Texas at Austin, Lone Star Stroke Research Consortium, Texas Department of State Health Services	Stroke	08/23	12/23
Alba, Israel
START, NCT03021928: Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation	Active, not recruiting	3	200	US	Time-To-Treatment Randomization	University of Texas at Austin, Lone Star Stroke Research Consortium, Texas Department of State Health Services	Stroke	08/23	12/23
ENDOLOW, NCT04167527: Endovascular Therapy for Low NIHSS Ischemic Strokes	Recruiting	2/3	200	Europe, Canada, US	Immediate mechanical thrombectomy(iMT) using EmboTrap Revascularization Device, EmboTrap III, Initial medical management (iMM)	Emory University, University of Calgary, University of Cincinnati, Heidelberg University, Children's Hospital Medical Center, Cincinnati	Cerebral Ischemia	12/24	12/24